Pharma
Milner Seminar - Focus on neurodegeneration
Join us for the first Milner Seminar of 2026! Talks will be followed by networking and refreshments. ...
Beyond Diagnosis: Erin’s Two-Decade Battle With PAH
Co-authored by Erin BakerFor Erin, pulmonary arterial hypertension isn’t just a diagnosis, it’s been a lifelong presence. Her journey spans family loss, her own young-adult diagnosis, two decades of treatment, and ultimately a life-saving lung transplant. Today, she uses her experience ...
Beta Launch of LYEONS Heart
The Beta Launch of 23 LYEONS Heart devices is now live!
Guardtech Group sign off record-breaking 2025 in style with a series of ground-breaking projects that are set to protect, preserve and improve human life
The East Anglian cleanroom construction specialists racked up more projects this year than ever before – including some very special life-saving ventures ...
Free CPD - Operate Your Fume Cupboards More Safely & Sustainably
From the UK experts in the science of fume containment - Clean Air. Join our free accredited CPD session and learn how to operate your fume cupboards effectively - cut carbon, save energy costs, and keep your lab personnel safe. ...
SCORES Athlete project relaunches with a fresh design on Mantal
The SCORES Athlete project—focused on understanding long-term health outcomes related to sports participation—has been refreshed and relaunched using Mantal’s modern digital infrastructure to enhance participant engagement and expand study reach. ...
Rapsodi & PD-Frontline studies successfully migrate to Mantal
The Rapsodi and PD-Frontline Parkinson’s studies have officially migrated to Mantal, enabling researchers to consolidate study operations, improve participant engagement, and future-proof their digital research infrastructure. ...
PREDICT-PD, the largest UK cross-sectional Parkinson’s study, adopts Mantal
PREDICT-PD, one of the UK’s most important Parkinson’s research initiatives, is now using the Mantal platform to expand participant reach, streamline digital assessments, and accelerate its mission to identify early markers of Parkinson’s disease. ...
Three years searching for answers: Jenna’s PAH story
Co-authored by Jenna MazorLiving with a rare disease can mean years of uncertainty before answers finally appear. For Jenna, the journey to her pulmonary arterial hypertension (PAH) diagnosis was long, exhausting, and often isolating. But her story is also one of persistence, self-advoc...
Functional Genomics Screening Laboratory wins OBN Award for Most Impactful Industry Collaboration
The Functional Genomics Screening Laboratory, based at the Milner Therapeutics Institute, has won an OBN Award in the category of Most Impactful Industry Collaboration. ...